Category Archives: Brain Injury Treatment

STOCKHOLM, April 30, 2020 /PRNewswire/ -- AlzeCure Pharma AB (publ) (UN STO: ALZCUR) and Karolinska Intitutet have had a long-term collaboration in the CNS field, and their joint doctoral student Mrta Dahlstrm is today defending her doctoral thesis at a public dissertation at Karolinska Institutet. Mrta Dahlstrm, PhD student and lead author, today at 09.30 CET presents her thesis with the title Drug Discovery targeting non-amyloid pathways in Alzheimer's disease. The thesis, which was made possible by generous support from Swedish Brain Power, examines two different target mechanisms for conceivable drug development in Alzheimer's disease, one of which concerns Nerve Growth Factor (NGF). Continue reading →

Its not only the immune system that must maintain a delicate balance. The bloodstream, too, exists in a perpetual tug-of-war between bleeding and clotting. Too much bleeding, and the smallest trauma can cause hemorrhage, even to the point of death (the danger faced by people with hemophilia); too far in the other direction, and clots will form in the absence of trauma, potentially obstructing blood vessels and causing lethal damage if they travel to the heart, lungs, or brain. Continue reading →

As the COVID-19 epidemic is making neurological emergencies harder to treat--and potentially more dangerous for the patient--neurology providers at Dukes three hospitals are rising to the challenge with robots, iPads, and an unprecedented level of collaboration. The patient in Durham Regional Hospital was unresponsive to questions Continue reading →

Patricia Berliner, the driver charged with with hitting and severely injuring a child as she was getting off a school bus near Whitefish, was arraigned in Flathead County District Court on Thursday. Berliner, whose vehicle hit 6-year old Jordana Hubble in early November, pleaded not guilty to a charge of felony criminal endangerment and was released on her own recognizance Continue reading →

As of 2018, astaggering 4.7 million veteranshad a service-related disability. Continue reading →

Rebion's blinq Vision Scanner selected as Honorable Mention in the Health and Wellness Category NEW YORK (PRWEB) April 30, 2020 The winners of Fast Company's 2020 World Changing Ideas Awards were announced today, honoring the businesses, policies, projects, and concepts that are actively engaged and deeply committed to flattening the curve when it comes to the climate crisis, social injustice, or economic inequality. Working tirelessly to change a status quo that leaves half of the children with amblyopia undetected and untreated is Boston-based start-up Rebion, recipient of an honorable mention award for eradicating amblyopia with the blinq vision scanner. Amblyopia ("lazy eye") and the related condition, strabismus, impairs 3 to 5% of the population, causing permanent vision loss if untreated. Continue reading →

Neurodegenerative diseases are real, and more than five million people in the United States. Moreover, at least 1 billion people across the globe are battling with one or more neurodegenerative disorders. It is worse than it sounds because many of these diseases can be fatal, leaving patients disabled, unable to think clearly or walk independently. Continue reading →

TOM PULLAR-STRECKER/STUFF ACC asked the Court of Appeal to reset the legal test for granting cover for treatment injuries. (File photo) ACC looks likely to win an argument that a High Court judge applied the wrong test in a guideline decision about who qualifies for accident compensation when treatment goes wrong. Continue reading →

Inflammation, although a life-saving immune response, can also range from unpleasant to downright life-threatening. When a body is injured or infected, the white blood cells rush to the affected area to release signaling proteins for protection, while also pushing out potential pathogen, and then start the healing process. Continue reading →

Exposing brain injury patients to a range of smell can determine whether they are going to recover, according to researchers behind a sniff test study. Continue reading →